MINNEAPOLIS
--(BUSINESS WIRE)--May. 20, 2013--
Piper
Jaffray
(NYSE: PJC), a leading investment bank and asset management
firm, today announced that
Andrew Gitkin
joined the firm as managing
director and head of
West Coast
biotechnology investment banking. Gitkin
will be based in the firm’s
San Francisco
office.
Gitkin brings nearly 20 years of healthcare financial services
experience to
Piper Jaffray
. He joins the firm from
Moelis & Co.
, where
he was a senior investment banker in the life sciences investment
banking group. Gitkin’s prior experience includes positions in
investment banking, equity research and asset management.
Gitkin has been recognized as part of the Institutional Investor
All-America team on numerous occasions for his prior research coverage
of biotechnology, healthcare services, medical supplies and technology.
He is a graduate of
Emory University
in
Atlanta
.
“Our healthcare group is a market-leading platform across life sciences,
medical technology and healthcare services. Andrew brings extensive
experience advising emerging companies in the biotech segment and
advising consolidators with strategic direction. His experience makes
him the ideal candidate to lead and grow our
West Coast
biotech
efforts,” commented
Bob
DeSutter
, head of
Piper Jaffray
healthcare investment banking.
"Andrew is a great addition to our healthcare team,” added
Chad
Abraham
, global co-head of investment banking and capital markets at
Piper Jaffray
. “Biotech is a strategic growth area for the firm and
Andrew’s hire highlights our continued focus on this franchise to
leverage our highly ranked advisory and equities business.”
Earlier this year,
Piper Jaffray
expanded its banking team by hiring
investment bankers,
Peter
Day
and
Jeff
Ammerman
who joined the firm from Leerink Swan and Jefferies,
respectively.
Piper Jaffray
has a global
healthcare
investment banking
and
capital
markets
team of 48. Since 2007, the team has represented clients in
238 transactions with an aggregate value of
$39 billion
. In addition,
the firm’s
10
healthcare senior research analysts
cover a broad spectrum of
sectors, including specialty pharmaceuticals, biotechnology, medical
technology, drug discovery, medical diagnostics, life science tools and
healthcare services, including information technology and alternate site
providers.
About
Piper Jaffray
Piper
Jaffray
is a leading investment bank and asset management firm
serving clients in the U.S. and internationally. Our proven advisory
teams combine deep industry, product and sector expertise with ready
access to capital. Founded in 1895, the firm is headquartered in
Minneapolis
and has offices across
the United States
and in
London
and
Zurich
.
www.piperjaffray.com
Since 1895. Member SIPC and NYSE. © 2013
Piper Jaffray Companies
,
800
Nicollet Mall
, Suite 800,
Minneapolis, Minnesota
55402-7020
Source:
Piper Jaffray Companies
Piper Jaffray Companies
Pamela Steensland, 612-303-8184
pamela.k.steensland@pjc.com
